Hisamitsu Pharmaceutical Co (TSE:4530) Additional Paid-In Capital : 円2,361 Mil(As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Additional Paid-In Capital?

Hisamitsu Pharmaceutical Co's quarterly additional paid-in capital stayed the same from May. 2023 (円2,361 Mil) to Aug. 2023 (円2,361 Mil) and stayed the same from Aug. 2023 (円2,361 Mil) to Nov. 2023 (円2,361 Mil).

Hisamitsu Pharmaceutical Co's annual additional paid-in capital increased from Feb. 2022 (円2,356 Mil) to Feb. 2023 (円2,361 Mil) but then stayed the same from Feb. 2023 (円2,361 Mil) to Feb. 2024 (円2,361 Mil).

Hisamitsu Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Additional Paid-In Capital Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Additional Paid-In Capital

Get a 7-Day Free Trial

2,272.00

2,352.00

2,356.00

2,361.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Additional Paid-In Capital	Get a 7-Day Free Trial															2,361.00	2,361.00	2,361.00	2,361.00	2,361.00

Hisamitsu Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Hisamitsu Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines